HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreasing tropomyosin phosphorylation rescues tropomyosin-induced familial hypertrophic cardiomyopathy.

Abstract
Studies indicate that tropomyosin (Tm) phosphorylation status varies in different mouse models of cardiac disease. Investigation of basal and acute cardiac function utilizing a mouse model expressing an α-Tm protein that cannot be phosphorylated (S283A) shows a compensated hypertrophic phenotype with significant increases in SERCA2a expression and phosphorylation of phospholamban Ser-16 (Schulz, E. M., Correll, R. N., Sheikh, H. N., Lofrano-Alves, M. S., Engel, P. L., Newman, G., Schultz Jel, J., Molkentin, J. D., Wolska, B. M., Solaro, R. J., and Wieczorek, D. F. (2012) J. Biol. Chem. 287, 44478-44489). With these results, we hypothesized that decreasing α-Tm phosphorylation may be beneficial in the context of a chronic, intrinsic stressor. To test this hypothesis, we utilized the familial hypertrophic cardiomyopathy (FHC) α-Tm E180G model (Prabhakar, R., Boivin, G. P., Grupp, I. L., Hoit, B., Arteaga, G., Solaro, R. J., and Wieczorek, D. F. (2001) J. Mol. Cell. Cardiol. 33, 1815-1828). These FHC hearts are characterized by increased heart:body weight ratios, fibrosis, increased myofilament Ca(2+) sensitivity, and contractile defects. The FHC mice die by 6-8 months of age. We generated mice expressing both the E180G and S283A mutations and found that the hypertrophic phenotype was rescued in the α-Tm E180G/S283A double mutant transgenic animals; these mice exhibited no signs of cardiac hypertrophy and displayed improved cardiac function. These double mutant transgenic hearts showed increased phosphorylation of phospholamban Ser-16 and Thr-17 compared with the α-Tm E180G mice. This is the first study to demonstrate that decreasing phosphorylation of tropomyosin can rescue a hypertrophic cardiomyopathic phenotype.
AuthorsEmily M Schulz, Tanganyika Wilder, Shamim A K Chowdhury, Hajer N Sheikh, Beata M Wolska, R John Solaro, David F Wieczorek
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 288 Issue 40 Pg. 28925-35 (Oct 04 2013) ISSN: 1083-351X [Electronic] United States
PMID23960072 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Mutant Proteins
  • Tropomyosin
  • Calcium
Topics
  • Animals
  • Calcium (metabolism)
  • Calcium Signaling
  • Cardiomyopathy, Hypertrophic, Familial (diagnostic imaging, metabolism, pathology, physiopathology)
  • Gene Expression Regulation
  • Heart Function Tests
  • Immunoblotting
  • Mice
  • Mice, Transgenic
  • Mutant Proteins (metabolism)
  • Myocardium (metabolism, pathology)
  • Myocytes, Cardiac (metabolism, pathology)
  • Myofibrils (metabolism)
  • Phosphorylation
  • Tropomyosin (metabolism)
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: